Spravato® Treatment in Norman, Oklahoma

KNOWLEDGE BASE

Everything you need to know about Spravato.

What is Spravato®?

Who may be considered?

Spravato® is the brand name for esketamine, a prescription nasal spray that affects the brain differently from traditional antidepressants. It is FDA-approved for treatment-resistant depression in adults, either by itself or with an oral antidepressant. It is also approved with an oral antidepressant for depressive symptoms in adults with major depressive disorder and acute suicidal thoughts or behavior.

Spravato may be considered for eligible adults after a comprehensive psychiatric evaluation and review of previous depression treatments, current medications, health history, symptoms, and treatment goals. Not everyone is an appropriate candidate, and an evaluation does not guarantee treatment.

• Adults experiencing treatment-resistant depression

• Patients who have not improved

  sufficiently with previous treatments

• Patients medically able to receive monitored in-office treatment

• Patients able to arrange safe transportation after every appointment

Best Candidates for Spravato®?

Spravato is not approved for home use and cannot be taken home from the clinic. Eligibility, treatment schedule, and continued treatment are determined by the prescribing provider.

YOUR TREATMENT VISIT

Supervised care in a friendly, comfortable environment.

Consultation and Enrollment

Before treatment begins, your provider reviews your psychiatric and medical history, previous treatments, current medications, potential risks, and whether Spravato may be appropriate. Eligible outpatients must also be enrolled in the SPRAVATO REMS.

Supervised Administration

You administer the prescribed nasal spray yourself under the direct observation of a healthcare professional. Your blood pressure and clinical condition are assessed according to treatment requirements.

Required Monitoring

You remain at the clinic under observation for at least two hours. Your provider determines when you are clinically ready to leave. Some patients may need longer monitoring.

Before every appointment

• Follow the clinic’s instructions about eating, drinking, and regular medications.

• Arrange transportation home before arriving.

• Wear comfortable clothing and plan for the full monitoring period.

After every appointment

• You cannot drive, operate machinery, or perform activities requiring complete alertness until the following day after a restful night’s sleep.

• You will need a responsible adult or arranged transportation to take you home.

The two-hour monitoring and next-day driving restriction are part of the official patient requirements. SPRAVATO REMS patient guidance.

Frequently asked questions

How long is each visit?

Patients must be monitored for at least two hours after administration. Allow additional time for check-in, preparation, clinical assessment, and discharge.

Can I drive myself home?

No. You must arrange transportation home and should not drive or perform activities requiring complete alertness until the following day after restful sleep.

How often will I receive treatment?

The schedule depends on the approved treatment plan, clinical response, tolerability, and provider recommendations. Your provider will explain the proposed schedule before treatment begins.

Does Spravato® work for everyone?

No treatment works for everyone. Results vary, and continued treatment depends on individual response, side effects, safety, and clinical judgment.

Request a Spravato® consultation

Contact Bishop Creek Medical to ask about eligibility, insurance or payment requirements, current availability, and the consultation process for Spravato treatment in Norman, Oklahoma.